Clinical trial
S.I.F.A. II: Prevention Of Thromboembolic Events In Patients With Nonrheumatic…
NCT00244426 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00244426 |
|---|---|
| Title | S.I.F.A. II: Prevention Of Thromboembolic Events In Patients With Nonrheumatic Atrial Fibrillation |
| Official title | II Italian Study on Atrial Fibrillation (S.I.F.A. II): Prevention of Thromboembolic Events in Patients With Non Valvular Atrial Fibrillation. |
| Acronym | SIFA |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Atrial Fibrillation |
| Intervention type | Drug |
| Interventions | indobufen, aspirin |
| Enrollment | 1,372 |
| Start date | Dec 1, 2000 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Oct 26, 2005 |
| Last update posted | Dec 19, 2018 |
| Countries | Italy |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: